SIC
TDOC icon

Starr International Company’s Teladoc Health TDOC Stock Holding History

Starr International Company’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-110,700
Closed -$7.35M – 32
2019
Q2 		$7.35M Buy
+110,700
New +$6.45M 3.06% 12

Other funds holding TDOC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Starr International Company's TDOC Position: Q3 2019 in Review

Starr International Company sold out of Teladoc Health (TDOC) in Q3 2019, closing a stake of 110,700 shares — an estimated $7.35M sold.

Starr International Company first reported a position in TDOC in Q2 2019 and held it in 1 quarter. The position peaked at $7.35M in Q2 2019. 377 funds tracked by Wall St. Rank hold TDOC as of Q3 2019.

  • Starr International Company reported no remaining Teladoc Health position as of Q3 2019 after selling out during the quarter.
  • Starr International Company sold 110,700 Teladoc Health shares in Q3 2019, an estimated $7.35M.
  • Starr International Company first reported a position in Teladoc Health in Q2 2019 and held it in 1 quarter.
  • Starr International Company's Teladoc Health position peaked at $7.35M in Q2 2019.
  • 377 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2019.

Based on Starr International Company's 13F filing for Q3 2019, filed 11 Oct 2019.